Medical management of Crohn's dsease

被引：39

作者：

Cummings, J. R. Fraser ^{[1
]}

Keshav, Satish ^{[1
]}

Travis, Simon P. L. ^{[1
]}

机构：

[1] John Radcliffe Hosp, Gastroenterol Unit, Oxford OX3 9DU, England

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2008年 / 336卷 / 7652期

关键词：

D O I：

10.1136/bmj.39547.603218.AE

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1062 / 1066

页数：5

共 26 条

[1] Review article: the evidence base for interventions used to maintain remission in Crohn's disease [J].

Akobeng, A. K. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2008, 27 (01) :11-18

[2] Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease [J].

Akobeng, AK ;

Gardener, E .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (01)

[3] Cost of illness of inflammatory bowel disease in the UK: a single centre retrospective study [J].

Bassi, A ;

Dodd, S ;

Williamson, P ;

Bodger, K .

GUT, 2004, 53 (10) :1471-1478

[4] Gastroenterology 2 - Inflammatory bowel disease: clinical aspects and established and evolving therapies [J].

Baumgart, Daniel C. ;

Sandborn, William J. .

LANCET, 2007, 369 (9573) :1641-1657

[5] Predictors of Crohn's disease [J].

Beaugerie, L ;

Seksik, P ;

Nion-Larmurier, I ;

Gendre, JP ;

Cosnes, J .

GASTROENTEROLOGY, 2006, 130 (03) :650-656

[6] Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials [J].

Bongartz, T ;

Sutton, AJ ;

Sweeting, MJ ;

Buchan, I ;

Matteson, EL ;

Montori, V .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (19) :2275-2285

[7]

CASPERSEN S, IN PRESS CLIN GASTRO

[8] American Gastroenterological Association Consensus Development Conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006 [J].

Clark, M. ;

Colombel, J.-F. ;

Feagan, B. C. ;

Fedorak, K. N. ;

Hanauer, S. B. ;

Kamm, M. A. ;

Mayer, L. ;

Regueiro, C. ;

Rutgeerts, P. ;

Sandborn, W. J. ;

Sands, B. E. ;

Schreiber, S. ;

Targan, S. ;

Travis, S. ;

Vermeire, S. .

GASTROENTEROLOGY, 2007, 133 (01) :312-339

[9] Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: The CHARM trial [J].

Colombel, Jean-Frederic ;

Sandborn, William J. ;

Rutgeerts, Paul ;

Enns, Robert ;

Hanauer, Stephen B. ;

Panaccione, Remo ;

Schreiber, Stefan ;

Byczkowski, Dan ;

Li, Ju ;

Kent, Jeffrey D. ;

Pollack, Paul F. .

GASTROENTEROLOGY, 2007, 132 (01) :52-65

[10] Genotypic analysis of thiopurine S-methyltransferase in patients with Crohn's disease and severe myelosuppression during azathioprine therapy [J].

Colombel, JF ;

Ferrari, N ;

Debuysere, H ;

Marteau, P ;

Gendre, JP ;

Bonaz, B ;

Soulé, JC ;

Modgliani, R ;

Touze, Y ;

Catala, P ;

Libersa, C ;

Broly, F .

GASTROENTEROLOGY, 2000, 118 (06) :1025-1030

← 1 2 3 →